Treatment Set TS351142 (Antigen Laboratories, Inc.)


Welcome to the PulseAid listing for the Treatment Set TS351142 drug offered from Antigen Laboratories, Inc.. This Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Increased Histamine Release [PE],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a NON-STANDARDIZED ALLERGENIC. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same NON-STANDARDIZED ALLERGENIC drug type category.
LABELER NAME / MANUFACTURER: Antigen Laboratories, Inc.
NON-PROPRIETARY NAME: Treatment Set TS351142
SUBSTANCE NAME: SORGHUM HALEPENSE POLLEN; PHLEUM PRATENSE POLLEN; QUERCUS ALBA POLLEN; QUERCUS VIRGINIANA POLLEN; QUERCUS RUBRA POLLEN; RUMEX CRISPUS POLLEN; RUMEX ACETOSELLA POLLEN; AMBROSIA TRIFIDA POLLEN; AMBROSIA
TYPE: NON-STANDARDIZED ALLERGENIC
PHARMA CLASS: Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Increased Histamine Release [PE],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
ROUTE: INTRADERMAL; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1986-10-31
END MARKETING DATE: 0000-00-00


Treatment Set TS351142 NON-STANDARDIZED ALLERGENIC Details:

Item DescriptionTreatment Set TS351142 from Antigen Laboratories, Inc.
LABELER NAME: Antigen Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: .01; 20000; .0033; .0033; .0033; .005; .005; .005; .005(g/mL; [BAU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL)
START MARKETING DATE: 1986-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49288-0952_57885b81-24e5-4a64-8d65-8a6517157bd9
PRODUCT NDC: 49288-0952
APPLICATION NUMBER: BLA102223

Other SORGHUM HALEPENSE POLLEN; PHLEUM PRATENSE POLLEN; QUERCUS ALBA POLLEN; QUERCUS VIRGINIANA POLLEN; QUERCUS RUBRA POLLEN; RUMEX CRISPUS POLLEN; RUMEX ACETOSELLA POLLEN; AMBROSIA TRIFIDA POLLEN; AMBROSIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Antigen Laboratories, Inc.Treatment Set TS351142